Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
G2B BioSolutions ApS
APS
Active
Reklamebeskyttelse
CVR 42437069
Hagens Alle 7, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2021 · 5 years old
1 ansatte
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
G2B BioSolutions ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
-1M
-100%
2023
0M
+100%
2024
0M
0%
2025
EBITDA
DKK millions
0M
-1M
-1M
-2M
-2M
0M
2021
0M
0%
2022
-2M
-200%
2023
0M
+100%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
-29
-171
-740
436
45
Staff expenses
-0
-41
-762
-54
-0
EBITDA
-29
-213
-1.501
381
45
Depreciation & amort.
-0
-0
-0
-0
-36
EBIT
-29
-213
-1.501
381
9
Net financials
-0
-5
-12
-11
-39
Profit before tax
-29
-217
-1.514
371
-30
Tax
-0
1
-0
-0
-167
Net profit
-29
-219
-1.514
371
137
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
14
68
90
592
635
Equity
11
-207
-1.721
-1.350
-1.213
Long-term debt
0
0
500
806
717
Short-term debt
3
275
1.311
1.137
1.132
Total debt
3
275
1.811
1.942
1.848
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
100.0%
Denne virksomhed
2021
2025
Soliditetsgrad
-191.2%
Denne virksomhed
38.2%
Markedsmedian
601% under markedet
2021
2025
Egenkapitalforrentning
13686400.0%
Denne virksomhed
18.4%
Markedsmedian
74382509% over markedet
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
305.4%
Denne virksomhed
2021
2025
Aktivomsætning (af bruttofortjeneste)
0.07×
Denne virksomhed
2021
2025
Gæld/egenkapital
1.52×
Denne virksomhed
0.62×
Markedsmedian
145% over markedet
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-06-03 – 2021-12-31
View
PDF
More on G2B BioSolutions ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
